Treating glioblastoma with dextrin-based polymers
Albeit far from clinical application, cyclodextrin-based polymers hold a strong potential as innovative treatment against glioblastoma.
Authors
- Roberta Cavalli (ORCID: https://orcid.org/0000-0002-2600-0661)
- Chiara Bastiancich (ORCID: https://orcid.org/0000-0003-2758-5654)
- Anna Scomparin (ORCID: https://orcid.org/0000-0003-4751-620X)
- Chiara Molinar
- Aurélie Tchoghandjian (ORCID: https://orcid.org/0000-0002-6573-6516)
Institutions
- Petra Christian University (ID)
- Centre National de la Recherche Scientifique (FR)
- Aix-Marseille Université (FR)
- Institut de Neurophysiopathologie (FR)
- University of Turin (IT)
Publication Details
- Journal
- Expert Opinion on Drug Delivery
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1080/17425247.2025.2570845
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00